When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Save Peptides Save Peptides BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA Peptide Reclassification 2026: What Researchers Want